 Connection
David Schwartz to Polymorphism, Genetic
This is a "connection" page, showing publications David Schwartz has written about Polymorphism, Genetic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.281 |
|
|
|
-
Long H, O'Connor BP, Zemans RL, Zhou X, Yang IV, Schwartz DA. The Toll-like receptor 4 polymorphism Asp299Gly but not Thr399Ile influences TLR4 signaling and function. PLoS One. 2014; 9(4):e93550.
Score: 0.363
-
Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, Gibson KF, Seibold MA, Brown KK, Talbert JL, Markin C, Kossen K, Seiwert SD, Murphy E, Noth I, Schwarz MI, Kaminski N, Schwartz DA. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA. 2013 Jun 05; 309(21):2232-9.
Score: 0.343
-
Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, Nishino M, Araki T, Zazueta OE, Kurugol S, Ross JC, San Jos? Est?par R, Murphy E, Steele MP, Loyd JE, Schwarz MI, Fingerlin TE, Rosas IO, Washko GR, O'Connor GT, Schwartz DA. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013 Jun 06; 368(23):2192-200.
Score: 0.342
-
Peljto AL, Steele MP, Fingerlin TE, Hinchcliff ME, Murphy E, Podlusky S, Carns M, Schwarz M, Varga J, Schwartz DA. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest. 2012 Dec; 142(6):1584-1588.
Score: 0.331
-
Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant. 2006 Jan-Feb; 20(1):30-6.
Score: 0.205
-
Schwartz DA, Cook DN. Polymorphisms of the Toll-like receptors and human disease. Clin Infect Dis. 2005 Nov 15; 41 Suppl 7:S403-7.
Score: 0.203
-
Palmer SM, Burch LH, Davis RD, Herczyk WF, Howell DN, Reinsmoen NL, Schwartz DA. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med. 2003 Sep 15; 168(6):628-32.
Score: 0.171
-
Schwartz DA, Blumhagen RZ, Fingerlin TE. Evolution of the Gain-of-Function MUC5B Promoter Variant. Am J Respir Crit Care Med. 2022 11 15; 206(10):1189-1191.
Score: 0.165
-
Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun. 2000 Nov; 68(11):6398-401.
Score: 0.143
-
Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eir?ksdott?r G, Aspelund T, Ross JC, San Jos? Est?par R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM. The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes. Eur Respir J. 2017 09; 50(3).
Score: 0.115
-
Das R, Subrahmanyan L, Yang IV, van Duin D, Levy R, Piecychna M, Leng L, Montgomery RR, Shaw A, Schwartz DA, Bucala R. Functional polymorphisms in the gene encoding macrophage migration inhibitory factor are associated with Gram-negative bacteremia in older adults. J Infect Dis. 2014 Mar 01; 209(5):764-8.
Score: 0.088
-
Gao Z, Dosman JA, Rennie DC, Schwartz DA, Yang IV, Beach J, Senthilselvan A. Association of Toll-like receptor 2 gene polymorphisms with lung function in workers in swine operations. Ann Allergy Asthma Immunol. 2013 Jan; 110(1):44-50.e1.
Score: 0.083
-
Macneal K, Schwartz DA. The genetic and environmental causes of pulmonary fibrosis. Proc Am Thorac Soc. 2012 Jul; 9(3):120-5.
Score: 0.080
-
Pahwa P, Karunanayake CP, Rennie DC, Chen Y, Schwartz DA, Dosman JA. Association of the TLR4 Asp299Gly polymorphism with lung function in relation to body mass index. BMC Pulm Med. 2009 Sep 21; 9:46.
Score: 0.066
-
Senthilselvan A, Dosman JA, Ch?nard L, Burch LH, Predicala BZ, Sorowski R, Schneberger D, Hurst T, Kirychuk S, Gerdts V, Cormier Y, Rennie DC, Schwartz DA. Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility. J Allergy Clin Immunol. 2009 May; 123(5):1034-40, 1040.e1-2.
Score: 0.064
-
Schwartz DA. Gene-environment interactions and airway disease in children. Pediatrics. 2009 Mar; 123 Suppl 3:S151-9.
Score: 0.064
-
Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med. 2008; 59:343-59.
Score: 0.059
-
Burch LH, Schwartz DA. Finding fibrosis genes: the lung. Methods Mol Med. 2005; 117:293-313.
Score: 0.048
-
Cook DN, Hollingsworth JW, Schwartz DA. Toll-like receptors and the genetics of innate immunity. Curr Opin Allergy Clin Immunol. 2003 Dec; 3(6):523-9.
Score: 0.044
-
Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002 Jul 18; 347(3):185-92.
Score: 0.040
-
Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002 May 13; 162(9):1028-32.
Score: 0.040
-
Schwartz DA. TLR4 and LPS hyporesponsiveness in humans. Int J Hyg Environ Health. 2002 Apr; 205(3):221-7.
Score: 0.040
-
Schwartz DA. The genetics of innate immunity. Chest. 2002 Mar; 121(3 Suppl):62S-68S.
Score: 0.039
-
Gao Z, Dosman JA, Rennie DC, Schwartz DA, Yang IV, Beach J, Senthilselvan A. Gender-specific associations between polymorphisms in the Toll-like receptor (TLR) genes and lung function among workers in swine operations. J Toxicol Environ Health A. 2018; 81(22):1186-1198.
Score: 0.031
-
Araki T, Putman RK, Hatabu H, Gao W, Dupuis J, Latourelle JC, Nishino M, Zazueta OE, Kurugol S, Ross JC, San Jos? Est?par R, Schwartz DA, Rosas IO, Washko GR, O'Connor GT, Hunninghake GM. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med. 2016 12 15; 194(12):1514-1522.
Score: 0.027
-
Chung JH, Peljto AL, Chawla A, Talbert JL, McKean DF, Rho BH, Fingerlin TE, Schwarz MI, Schwartz DA, Lynch DA. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism. Chest. 2016 05; 149(5):1215-22.
Score: 0.026
-
Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, Murphy E, Johnston SL, Schwartz DA, Wells AU, Cookson WO, Maher TM, Moffatt MF. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Oct 15; 190(8):906-13.
Score: 0.024
-
Kumpf O, Giamarellos-Bourboulis EJ, Koch A, Hamann L, Mouktaroudi M, Oh DY, Latz E, Lorenz E, Schwartz DA, Ferwerda B, Routsi C, Skalioti C, Kullberg BJ, van der Meer JW, Schlag PM, Netea MG, Zacharowski K, Schumann RR. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit Care. 2010; 14(3):R103.
Score: 0.017
-
Senthilselvan A, Ch?nard L, Kirychuk S, Predicala B, Schwartz DA, Burch LH, Rennie DC, Willson PJ, Dosman JA. Gender-related tumor necrosis factor-alpha responses in na?ve volunteers with Toll-like receptor 4 polymorphisms exposed in a swine confinement facility. J Interferon Cytokine Res. 2009 Dec; 29(12):781-90.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|